It is ONS' position that any nurse involved in the care of a patient receiving anti-neoplastic medications be deemed competent by their institutions to do so. Preparation for any nurse administering or caring for clients receiving chemotherapy, biologics, and/or immunotherapy should encompass both didactic (classroom) education and clinical practicum. This is stated in the ONS position statement on the Education of the Nurse who Administers and Cares for the Individual Receiving Chemotherapy, Targeted Therapy and Immunotherapy. In this position statement, ONS does not differentiate between settings (oncology or non-oncology), indications, routes or doses when advocating for practice standards related to anti-neoplastic administration. The ASCO/ONS Chemotherapy Administration Safety Standards, standard 3.18: "Chemotherapy is administered by a qualified physician, physicians assistant, registered nurse, or advanced practice nurse defined in standard 1.1" These standards, for the purposes of administration, do not delineate between intravenous chemotherapy and oral chemotherapy.